Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Language
Publication year range
1.
Chem Commun (Camb) ; 2024 Jul 19.
Article in English | MEDLINE | ID: mdl-39028206

ABSTRACT

A temperature-programmed reduction method was developed to stabilize SAPO-37 and molybdenum-(oxy)-carbide-loaded SAPO-37 (SAP-37MoCR). The inorganic framework (Faujasite type SAPO-37) was retained for the first time even after treatment at 550 °C and was confirmed through powder XRD and SEM analysis. SAP-37MoCR exhibits strong acidic sites and is a promising catalyst for MTBE synthesis. Furthermore, the catalyst is stable and recyclable.

2.
Lupus ; 27(14): 2245-2252, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30394835

ABSTRACT

OBJECTIVES: We investigated the efficacy and safety of tacrolimus (TAC) by monitoring its serum concentration for mothers and infants in pregnant patients with systemic lupus erythematosus (SLE). METHODS: We measured trough concentrations of TAC in 25 pregnant patients with SLE to assess influence of TAC on the disease activity. Additionally, we measured the concentrations of TAC in umbilical arterial blood, breast milk, and breastfed infants to investigate the safety of TAC for the mothers and infants. RESULTS: The trough concentrations of TAC in the mothers significantly decreased in the second trimester as compared with those before pregnancy. However, the decrease in the trough concentrations of TAC did not lead to the deterioration of SLE. When examined, the doses of TAC were significantly lower in the second trimester and postpartum in the deteriorating group than those in the non-deteriorating group. There were no adverse events by TAC in mothers and fetuses. The concentrations of TAC in the umbilical cord blood were lower than those in the maternal blood. The relative infant dose in breastfed infants of TAC was < 1%. The level of TAC in infant bloods was below detectable limits. CONCLUSION: These findings suggest that TAC is one of the most effective and safest immunosuppressive drugs for use in pregnant patients with SLE.


Subject(s)
Immunosuppressive Agents/therapeutic use , Lactation , Lupus Erythematosus, Systemic/drug therapy , Tacrolimus/therapeutic use , Adult , Breast Feeding , Female , Fetal Blood/chemistry , Humans , Immunosuppressive Agents/blood , Infant , Infant, Newborn , Japan , Milk, Human/chemistry , Pregnancy , Severity of Illness Index , Tacrolimus/blood
3.
BMC Bioinformatics ; 16 Suppl 17: S5, 2015.
Article in English | MEDLINE | ID: mdl-26679199

ABSTRACT

MOTIVATION: The identification of new therapeutic uses of existing drugs, or drug repositioning, offers the possibility of faster drug development, reduced risk, lesser cost and shorter paths to approval. The advent of high throughput microarray technology has enabled comprehensive monitoring of transcriptional response associated with various disease states and drug treatments. This data can be used to characterize disease and drug effects and thereby give a measure of the association between a given drug and a disease. Several computational methods have been proposed in the literature that make use of publicly available transcriptional data to reposition drugs against diseases. METHOD: In this work, we carry out a data mining process using publicly available gene expression data sets associated with a few diseases and drugs, to identify the existing drugs that can be used to treat genes causing lung cancer and breast cancer. RESULTS: Three strong candidates for repurposing have been identified- Letrozole and GDC-0941 against lung cancer, and Ribavirin against breast cancer. Letrozole and GDC-0941 are drugs currently used in breast cancer treatment and Ribavirin is used in the treatment of Hepatitis C.


Subject(s)
Computational Biology/methods , Databases, Genetic , Drug Repositioning/methods , Gene Expression Regulation, Neoplastic , Antineoplastic Agents/therapeutic use , Breast Neoplasms/drug therapy , Breast Neoplasms/genetics , Female , Hepatitis C/genetics , Humans , Letrozole , Lung Neoplasms/genetics , Nitriles/therapeutic use , Triazoles/therapeutic use
4.
East Mediterr Health J ; 9(3): 296-308, 2003 May.
Article in English | MEDLINE | ID: mdl-15751922

ABSTRACT

ABSTRACT At the outpatient clinic of Ain Shams University Maternity Hospital, perceptions and practices of 1000 women regarding their reproductive health rights (reproductive rights) were evaluated. The majority had positive perceptions about their rights to reproductive health; however, 30% disagreed with prohibitions of discrimination against women, particularly prohibitions of female genital mutilation (FGM). A significant association was found between perceptions of sexual rights and demographic characteristics and between education and practices regarding early detection of cancer. No significant association was found between education and concepts of adolescent health education as a reproductive right. Programmes about women's reproductive rights that emphasize the issue of sexual health through religious education are recommended as one of the best strategies for the eradication of FGM.


Subject(s)
Attitude to Health , Reproductive Medicine , Reproductive Rights/psychology , Women's Health , Women's Rights , Women/psychology , Adult , Circumcision, Female , Educational Status , Egypt , Family Planning Services , Female , Health Knowledge, Attitudes, Practice , Health Services Accessibility/standards , Hospitals, Maternity , Hospitals, University , Humans , Marriage/psychology , Mass Screening , Needs Assessment , Outpatient Clinics, Hospital , Prejudice , Reproductive Medicine/education , Reproductive Rights/education , Rural Population/statistics & numerical data , Sex Education , Surveys and Questionnaires , Urban Population/statistics & numerical data , Women/education , Women's Rights/education
5.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-119278

ABSTRACT

At the outpatient clinic of Ain Shams University Maternity Hospital, perceptions and practices of 1000 women regarding their reproductive health rights [reproductive rights] were evaluated. The majority had positive perceptions about their rights to reproductive health; however, 30% disagreed with prohibitions of discrimination against women, particularly prohibitions of female genital mutilation [FGM]. A significant association was found between perceptions of sexual rights and demographic characteristics and between education and practices regarding early detection of cancer. No significant association was found between education and concepts of adolescent health education as a reproductive right. Programmes about women's reproductive rights that emphasize the issue of sexual health through religious education are recommended as one of the best strategies for the eradication of FGM


Subject(s)
Circumcision, Female , Educational Status , Family Planning Services , Health Knowledge, Attitudes, Practice , Health Services Accessibility , Hospitals, Maternity , Marriage , Mass Screening , Outpatient Clinics, Hospital , Attitude to Health
SELECTION OF CITATIONS
SEARCH DETAIL
...